DE69521295D1 - Triazolderivate - Google Patents
TriazolderivateInfo
- Publication number
- DE69521295D1 DE69521295D1 DE69521295T DE69521295T DE69521295D1 DE 69521295 D1 DE69521295 D1 DE 69521295D1 DE 69521295 T DE69521295 T DE 69521295T DE 69521295 T DE69521295 T DE 69521295T DE 69521295 D1 DE69521295 D1 DE 69521295D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- pct
- alkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9402016A GB9402016D0 (en) | 1994-02-02 | 1994-02-02 | Therapeutic agents |
| PCT/GB1995/000134 WO1995021166A1 (en) | 1994-02-02 | 1995-01-24 | Triazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69521295D1 true DE69521295D1 (de) | 2001-07-19 |
| DE69521295T2 DE69521295T2 (de) | 2001-11-08 |
Family
ID=10749758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69521295T Expired - Fee Related DE69521295T2 (de) | 1994-02-02 | 1995-01-24 | Triazolderivate |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5902819A (de) |
| EP (1) | EP0741722B1 (de) |
| JP (1) | JPH09508408A (de) |
| AT (1) | ATE202100T1 (de) |
| AU (1) | AU685219B2 (de) |
| CA (1) | CA2182196A1 (de) |
| DE (1) | DE69521295T2 (de) |
| GB (1) | GB9402016D0 (de) |
| WO (1) | WO1995021166A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9523583D0 (en) * | 1995-11-17 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| GB9610978D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| FR2767827A1 (fr) * | 1997-09-03 | 1999-02-26 | Adir | Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ283018B6 (cs) * | 1991-02-01 | 1997-12-17 | Merck Sharp And Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi |
| EP0630374B1 (de) * | 1992-03-13 | 2001-09-05 | MERCK SHARP & DOHME LTD. | Imidazol-, triazol- und tetrazolderivate |
| NZ251047A (en) * | 1992-04-10 | 1996-09-25 | Pfizer | Acylaminoindole derivatives and medicaments |
| AU672802B2 (en) * | 1992-07-24 | 1996-10-17 | Merck Sharp & Dohme Limited | Imidazole, triazole and tetrazole derivatives |
| IL106445A (en) * | 1992-07-30 | 1998-01-04 | Merck Sharp & Dohme | History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them |
-
1994
- 1994-02-02 GB GB9402016A patent/GB9402016D0/en active Pending
-
1995
- 1995-01-24 EP EP95906415A patent/EP0741722B1/de not_active Expired - Lifetime
- 1995-01-24 DE DE69521295T patent/DE69521295T2/de not_active Expired - Fee Related
- 1995-01-24 AT AT95906415T patent/ATE202100T1/de not_active IP Right Cessation
- 1995-01-24 JP JP7520435A patent/JPH09508408A/ja not_active Withdrawn
- 1995-01-24 US US08/676,350 patent/US5902819A/en not_active Expired - Fee Related
- 1995-01-24 CA CA002182196A patent/CA2182196A1/en not_active Abandoned
- 1995-01-24 WO PCT/GB1995/000134 patent/WO1995021166A1/en active IP Right Grant
- 1995-01-24 AU AU14613/95A patent/AU685219B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU685219B2 (en) | 1998-01-15 |
| EP0741722B1 (de) | 2001-06-13 |
| CA2182196A1 (en) | 1995-08-10 |
| JPH09508408A (ja) | 1997-08-26 |
| US5902819A (en) | 1999-05-11 |
| WO1995021166A1 (en) | 1995-08-10 |
| AU1461395A (en) | 1995-08-21 |
| DE69521295T2 (de) | 2001-11-08 |
| ATE202100T1 (de) | 2001-06-15 |
| GB9402016D0 (en) | 1994-03-30 |
| EP0741722A1 (de) | 1996-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69413542D1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
| SE0104332D0 (sv) | Therapeutic agents | |
| NO20055714L (no) | Inhibitorer av fosfatidylinositol 3-kinase | |
| ATE383338T1 (de) | N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung | |
| IS1959B (is) | Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra | |
| ATE194340T1 (de) | Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten | |
| ATE522525T1 (de) | Arylsubstituierte pyrazolamidverbindungen, die als kinase-inhibitoren von nutzen sind | |
| ATE206122T1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
| ATE484495T1 (de) | Fungizide | |
| IS2020B (is) | Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra | |
| ATE177096T1 (de) | 4-substituierte 1,2,4-triazolderivate | |
| DE69231445D1 (de) | Triazole enthaltende antifungizide mittel | |
| ATE72431T1 (de) | 5-gliedrige heterocyclische angiotensinumwandlungsenzym-inhibitoren. | |
| DE69230141D1 (de) | Von pyridin und imidazol abgeleitete mittel für kardiovaskuläre krankheiten | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| ATE399755T1 (de) | Aminoalkoholderivate, pharmazeutische zusammensetzungen, die diese enthalten, und verwendung davon | |
| DE69521295D1 (de) | Triazolderivate | |
| ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
| HRP20030810B1 (en) | Novel fungicide compositions based on pyridylmethylbenzamide and propamocarb derivative | |
| ES2195016T3 (es) | Medicamento contra la trombocitopenia. | |
| ATE338749T1 (de) | Derivate von 3-phenyl-n-(2-(4-benzyl)piperidin-1- yl)ethyl) acrylamid mit ccr-3-rezeptor antagonistischer wirkung zur verwendung bei der behandlung von entzündungen und allergischen leiden | |
| ES2119454T3 (es) | Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina. | |
| FR2823749A1 (fr) | Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| HUP0202237A2 (hu) | Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk | |
| TW328088B (en) | Imidazolidinone derivative and its acid additional salt, for treatment of senile dementia and the process for preparing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |